Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Department of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan.
J Med Ultrason (2001). 2024 Apr;51(2):227-233. doi: 10.1007/s10396-024-01458-4. Epub 2024 May 3.
Endoscopic ultrasonography (EUS) provides high spatial resolution and more detailed images than other diagnostic modalities. Furthermore, EUS-guided tissue acquisition (EUS-TA), such as EUS-guided fine needle aspiration or biopsy (EUS-FNA/FNB), is an indispensable tool in pancreaticobiliary disease diagnostics, supporting a conclusive pathological diagnosis. In this review, we evaluate the current status and the usefulness of EUS-TA for the diagnostics of the following biliary tract diseases: (A) biliary stricture diagnostics, (B) biliary tract cancer (BTC) itself, and (C) staging of advanced BTC. Previous reports have shown that EUS-FNA for biliary lesions is a safe procedure that is useful in differentiating biliary cancer from benign lesions and in the staging of BTC. On the other hand, the diagnostic performance of EUS-TA for bile duct lesions is reported to be similar to that of transpapillary biopsy. Overall, EUS-TA for biliary lesions may be a safe and effective method, but it should be performed with an understanding of the risk of serious adverse events such as bile leakage and peritoneal dissemination of cancer. It is recommended for distal biliary stricture lesions for which endoscopic retrograde cholangiopancreatography cannot confirm the diagnosis or gallbladder lesions if they do not require the needle to pass through the biliary lumen.
内镜超声检查(EUS)提供的空间分辨率高于其他诊断方式,图像更详细。此外,EUS 引导下的组织获取(EUS-TA),如 EUS 引导下的细针抽吸或活检(EUS-FNA/FNB),是胰胆疾病诊断中不可或缺的工具,有助于获得明确的病理诊断。在这篇综述中,我们评估了 EUS-TA 用于以下胆道疾病诊断的现状和作用:(A)胆道狭窄的诊断,(B)胆道癌(BTC)本身,以及(C)BTC 的分期。既往的报告显示,EUS-FNA 对胆道病变是一种安全的操作,有助于区分胆道癌和良性病变,并对 BTC 进行分期。另一方面,EUS-TA 对胆管病变的诊断性能与经乳头活检相似。总体而言,EUS-TA 对胆道病变可能是一种安全有效的方法,但应了解胆漏和癌症腹膜播散等严重不良事件的风险。对于内镜逆行胰胆管造影术(ERCP)无法确诊的远端胆道狭窄病变或无需针穿过胆管腔的胆囊病变,推荐使用。